Cargando…

Unlocking Genetic Profiles with a Programmable DNA‐Powered Decoding Circuit

Human genetic architecture provides remarkable insights into disease risk prediction and personalized medication. Advances in genomics have boosted the fine‐mapping of disease‐associated genetic variants across human genome. In healthcare practice, interpreting intricate genetic profiles into action...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junlan, Zhang, Chao, Song, Jinxing, Zhang, Qing, Zhang, Rongjun, Zhang, Mingzhi, Han, Da, Tan, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369254/
https://www.ncbi.nlm.nih.gov/pubmed/37116171
http://dx.doi.org/10.1002/advs.202206343
Descripción
Sumario:Human genetic architecture provides remarkable insights into disease risk prediction and personalized medication. Advances in genomics have boosted the fine‐mapping of disease‐associated genetic variants across human genome. In healthcare practice, interpreting intricate genetic profiles into actionable medical decisions can improve health outcomes but remains challenging. Here an intelligent genetic decoder is engineered with programmable DNA computation to automate clinical analyses and interpretations. The DNA‐based decoder recognizes multiplex genetic information by one‐pot ligase‐dependent reactions and interprets implicit genetic profiles into explicit decision reports. It is shown that the DNA decoder implements intended computation on genetic profiles and outputs a corresponding answer within hours. Effectiveness in 30 human genomic samples is validated and it is shown that it achieves desirable performance on the interpretation of CYP2C19 genetic profiles into drug responses, with accuracy equivalent to that of Sanger sequencing. Circuit modules of the DNA decoder can also be readily reprogrammed to interpret another pharmacogenetics genes, provide drug dosing recommendations, and implement reliable molecular calculation of polygenic risk score (PRS) and PRS‐informed cancer risk assessment. The DNA‐powered intelligent decoder provides a general solution to the translation of complex genetic profiles into actionable healthcare decisions and will facilitate personalized healthcare in primary care.